Introduction: Studies have reported alcohol consumption and genetic variants as major contributing factors for esophageal squamous cell carcinoma (ESCC). However, the complicated interactions between alcohol and genetic factors involved in alcohol metabolism have not been well elucidated with respect to augmented risk of ESCC.
Methods: We performed a large population-based casecontrol study in a Chinese city with a high ESCC incidence by enrolling 1190 case patients and 1883 controls. We integrated candidate single-nucleotide polymorphism data, detailed alcohol consumption records, gene-alcohol interactions, and single-nucleotide polymorphism functional information to untangle the complicated relationship between alcohol, variants of genes encoding alcohol metabolism enzymes, and ESCC risk. The gene-alcohol interaction was tested by including their product term in a multivariable logistic regression model. Synergy index and ratio of ORs were calculated to assess interaction on additive and multiplicative scale, respectively.
Results: We confirmed two ESCC susceptibility loci, rs671 in aldehyde dehydrogenase 2 family member gene (ALDH2) and rs1042026 in alcohol dehydrogenase 1B (class I), beta polypeptide gene (ADH1B), that significantly altered alcohol consumption behavior and subsequently modified the association between alcohol consumption and ESCC risk. The rs671(A) allele was associated with ESCC risk in alcohol drinkers (adjusted odds ratio ¼1.98, 95% confidence interval [CI]: 1.51-2.60) but not in nondrinkers. Healthy individuals who carry different ALDH2 and ADH1B genotypes exhibit diversified drinking behavior, with the proportion of drinkers varying between 23.7% and 54.3%. Among individuals with a fast ethanol oxidization rate, we observed a strong interaction between heavy alcohol consumption and ethanal oxidization rate on both the additive scale (synergy index 4.80 [95% CI: 1.82-12.68]) and the multiplicative scale (ratio of ORs 2.93, 95% CI: 1.39-6.35).
Conclusions: Our observation highlights the need for preventing excessive use of alcohol, especially in individuals harboring active alcohol dehyrogenase and inactive ALDH2 variants.
Introduction
East Asia has the highest incidence of esophageal cancer, with age-standardized incidence rates (world standard population) of 17.0 in males and 5.4 in females per 100,000 person-years. 1 Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma are the two major histopathological subtypes. The incidence and mortality rates of ESCC, which is the predominant histological type, show a wide geographical variation. A particularly high incidence has been reported in selected regions of the People's Republic of China. 1 For example, the incidence in certain high-risk Chinese regions is 20 times higher than that in low-risk Western Africa, 1 suggesting that both genetic and environmental factors contribute to the development of ESCC.
Because excess alcohol consumption poses a significant global public health issue, there have been efforts to minimize exposure to alcohol, which has important implications for ESCC prevention and alcohol abuse. 2, 3 However, variation in alcohol consumption alone does not explain the differing incidence between regions at high and low risk of ESCC. Other etiological factors associated with ESCC should be further explored. Previous genome-wide association studies (GWASs) and candidate genetic case-control studies in individuals of European and Asian ancestry have suggested that a set of alcohol (ethanol) metabolism-related genetic variations, primarily in alcohol dehydrogenase (ADH) genes and aldehyde dehydrogenase 2 family member gene (ALDH2), confer susceptibility to ESCC. 4, 5 In the alcohol metabolism pathway, ethanol is first oxidized by ADH into acetaldehyde (ethanal) and subsequently oxidized by ALDH2 to produce acetic acid (ethanoic acid) ( Supplementary Fig. 1 ). Variants in both ADH and ALDH2 genes can influence alcohol metabolism by either increasing turnover of ethanol to acetaldehyde or deactivating oxidization function of acetaldehyde to harmless acetic acid. 6, 7 This can result in accumulation of acetaldehyde, which is a known mutagen and carcinogen that causes DNA damage and promotes ESCC development. 8 In addition, ADH and ALDH2 alleles may influence individual alcohol consumption habits and risk of alcoholism development. Earlier studies have observed an interaction effect between these loci and alcohol intake on ESCC risk. 4, 5 However, it was difficult to determine the exact contribution of individual variants because the functions of the variants were not taken into account in interpreting genotypic effects and the complex LD patterns over the study regions. Moreover, the three-way interaction between ADH, ALDH2, and alcohol intake in relation to ESCC risk has not been thoroughly studied and GWAS studies often lack detailed information on the amount of alcohol consumed. Given that certain ESCC loci act in an environmentally responsive manner, true associations might not be detected without accounting for environmental risk factors. Thus, to further investigate these previously identified susceptibility loci that related to alcohol metabolism, incorporation of alcohol consumption status, in particular detailed consumption levels, may yield additional insights. Taixing, which is a city located in eastern China, is one of the regions with the highest ESCC incidence rates. However, the etiology underlying high ESCC incidence is not well understood for this particular region. We have conducted a large populationbased case-control study on ESCC, in which detailed lifestyle information has been collected and blood samples biobanked. To the best of our knowledge, this is the first study reporting on the interaction between alcohol consumption and variations in alcohol metabolismrelated genes by integrating single-nucleotide polymorphism (SNP) functions and effect sizes. The results suggest that there is important clinical utility in developing a predictive risk assessment tool for ESCC screening to facilitate the prevention or detection of ESCC at earlier stages to improve clinical outcomes.
Patients and Methods

Study Design
We performed a case-control study in Taixing, a Chinese city with a population of approximately 1.13 million. The study design has been described in earlier studies. [9] [10] [11] We attempted to enroll all individuals with incident esophageal cancer (i.e., patients with esophageal cancer that was newly diagnosed between October 2010 and September 2013). Inclusion in the study participation was limited to individuals who were 40 to 85 years old and had lived in Taixing for at least 5 years, so as to ensure enough of a time window for exposure to take effect and to exclude new migrants whose genetic background might be different from that of the original Taixing population. More than 90% of the patients were recruited from four local, very large hospitals, including the Taixing People's Hospital, the Second People's Hospital of Taixing, the Third People's Hospital of Taixing, and the Taixing Chinese Medicine Hospital. Each patient was asked to complete a questionnaire by trained interviewers if suspected of having esophageal cancer by an endoscopic examination. Patients in whom esophageal cancer was not histopathologically confirmed were excluded from this study. To additionally recruit patients with esophageal cancer who were possibly missed by the four aforementioned hospitals, we cross-checked with the Taixing Cancer Registry (http:// www.tzcdc.org/), in which a list of incident cases has been compiled every year. The Taixing Cancer Registry was established and has been maintained by the Taixing Center for Disease Control and Prevention since 1998. 12, 13 It is one of the earliest 48 local population-based cancer registries in the People's Republic of China and is both monitored and evaluated by the National Central Cancer Registry. Cancer diagnoses are reported to the local cancer registry from multiple sources, including local hospitals, community health centers, the Urban Resident Basic Medical Insurance Program, and the New Rural Cooperative Medical Scheme. We cross-checked the cases collected from hospitals against the registry database and determined that at least 80% had already been reported, indicating robust data accuracy and high quality of the registry.
During 2010-2013, we recruited 1681 case patients in total, including 1401 patients with suspected esophageal cancer from the hospitals and 280 supplementary case patients from the local Cancer Registry ( Supplementary  Fig. 2 ). We collected 1499 formalin-fixed and paraffinembedded tissue blocks mainly from biopsy samples (with 22 samples from surgical resection), and for those for whom tissue blocks were unavailable, 83 original pathological reports after surgical resection were substituted. The remaining 99 nonsurgical case patients were excluded. After review of the pathological sections by the study pathologist or a reassessment of the surgical pathological reports, 1418 case patients with ESCC and 81 patients with non-ESCC were identified. Approximately 78% of incident cases in the study base were included in this study on the basis of the estimated number from the cancer incidence and mortality data for Taixing. 14 We identified potential control subjects from the general population and frequency-matched these to case patients by sex and 5-year age group. The controls were randomly selected from the same study region, without further matching on the basis of geographic subregions, allowing for analysis of possible geographical effect on ESCC risk. We examined the geographical distribution of the controls and confirmed that all towns were covered. Of 3501 randomly selected controls from Taixing Population Registry, 643 had died before being contacted, had emigrated, or could not be reached, leaving 2858 eligible subjects. To increase the response rate, symbolic incentives and a basic physical health examination were provided to the participants, with publicity and support from local government. For the nonresponders, we also made a second attempt to visit their house. Consequently, 2011 controls were recruited, with a participation rate of 70.4% (2011 of 2858). After exclusion of controls older than 85 years, our final total was 1992 controls.
After further excluding 111 participants without blood samples, we conducted our candidate genetic association study by using a total of 1249 case patients and 1983 control subjects.
All 
SNP Genotyping and Quality Control
A total of 31 SNPs from 15 genes were selected for genotyping; they were selected on the basis of two criteria: (1) the SNPs had been previously reported to associate with ESCC in candidate or GWAS studies and (2) the SNPs were in the alcohol metabolism pathways or associated with alcohol consumption. 15 Specifically, our primary genes of interest are those in the alcohol metabolism pathways, 4,7 which included the following nine genes: alcohol dehydrogenase 1A (class I); alpha polypeptide gene (ADH1A); alcohol dehydrogenase 1B (class I), beta polypeptide gene (ADH1B); alcohol dehydrogenase 1B (class I), gamma polypeptide gene (ADH1C); alcohol dehydrogenase 4 (class II), pi polypeptide gene (ADH4); alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5); alcohol dehydrogenase 6 (class V) gene (ADH6); alcohol dehydrogenase 7 (class IV) mu or sigma polypeptide gene (ADH7); ALDH2; and cytochrome P450 family 2 subfamily E member 1 gene (CYP2E1) (also a carcinogen-metabolizing enzyme). Some of these genes are known to display genetic polymorphisms altering individual alcohol-oxidizing capacity and drinking behavior. 8, 16 One gene encodes for a one-carbon metabolism enzyme, methylenetetrahydrofolate reductase, which has been reported to modify the association between alcohol consumption habits and pancreatic cancer risk. 17 Three genes, HECT domain E3 ubiquitin protein ligase 4 gene (HECTD4 [formerly known as C12orf51), coiled-coil domain containing 63 gene (CCDC63), and myosin light chain 2 gene (MYL2), harbor SNPs that have been shown to be associated with alcohol consumption, 18 whereas the remaining two genes, insulin like growth factor binding protein 2 gene (IGFBP2) and solute carrier family 10 member 2 gene (SLC10A2), have been demonstrated to modify the association between alcohol consumption and ESCC risk. 4 The SNPs were genotyped by using a three-round multiplex polymerase chain reaction procedure with next-generation sequencing technology. 19 The two bestknown SNPs, rs671 on ALDH2 and rs1229984 on ADH1B, were included in our genotyping list, with the latter not genotyped directly. Because of a limited read length of approximately 200 bases and polymerase chain reaction amplification step needed in the nextgeneration sequencing technology, primer design and analysis were very challenging (given that rs1229984 is highly homologous). The SNP was detected in only a percentage of samples and thus considered to be a lowquality locus that did not pass quality control. Therefore, rs1042026, in high linkage disequilibrium (LD) with rs1229984, was used as a surrogate marker instead ( Supplementary Fig. 3A ). SNPs in LD with rs671 and rs1042026 are displayed in regional LD plots in Supplementary Figure 3A .
We genotyped 1249 case patients with ESCC and 1983 controls. After exclusion of 59 case patients and 100 controls with a call rate of 0.9 or less, 1190 case patients and 1883 controls passed quality control and were included in the analysis. All SNPs had a call rate of at least 0.94 in all samples and had Hardy-Weinberg equilibrium according to chi-square tests, with p values of 0.05 or higher in the controls (Supplementary Table 1 and Supplementary Fig. 4 ). Detailed SNP annotation and the quality control metrics for missingness and HardyWeinberg equilibrium are shown in Supplementary  Table 1 . Supplementary Figure 4 displays sample and SNP missingness rate, respectively. To ensure genotyping accuracy, we also implemented quality control procedures, such as by including negative controls. In addition, a randomly selected 8% of total samples were genotyped twice and the consistency was higher than 98%. The average sequencing depth was 1225Â. Through LD analyses, an additional 497 SNPs showed LDs with a minimum mean r 2 value of 0.85 (Supplementary Table 2 ). All SNPs had a minor allele frequency of 0.1 or more in both the case patient and control samples, rendering adequate statistical power.
Alcohol Variables Assessment
Trained staff interviewed all participants in person by using a structured electronic questionnaire that included a section on alcohol consumption. Each participant was asked for history of alcohol consumption up to the interview date. Specifically, participants were asked at what age they started drinking, at what age they stopped drinking permanently (for ex-drinkers), the amount that they typically drank, types of alcohol, how often they drank, and the number of years for which they had consumed alcohol. To minimize recall bias, most case patients were asked about alcohol consumption before their cancer diagnosis.
Ex-drinkers were defined as those who had stopped drinking alcohol for at least 2 years before the interview date. Drinking duration was the time between age at which drinking was started and age at permanent cessation for ex-drinkers, and between starting age and age at interview for current drinkers, with subtraction of cumulative duration of any temporal cessation episodes. Amount of alcohol consumed were measured in cups for Chinese and imported spirits and in bottles for beer, fruit wine, yellow rice wine, and grape wine and then converted from cups/bottles to grams. Cumulative drinking amount (in g/day-years) was calculated as the amount typically consumed (in grams) divided by the frequency of drinking times the duration of drinking (in years) across multiple types of alcohol.
Statistical Analysis
The chi-square test was used to assess the statistical significance of 2Â2 contingency tables (Supplementary Table 2 ). Logistic regression was applied to permit calculation of statistical significance of SNPs on the basis of univariate, and multivariable models controlling for age, sex, alcohol consumption, tea consumption, smoking, how often the teeth were brushed, wealth score, and family history of esophageal cancer. Wealth score was calculated on the basis of ownership of a series of household appliances, including a car, television, and washing machine, as well as on the basis of other variables, such as size of house area per person, by using a multiple correspondence analysis. 20 These scores were categorized by quantiles of observed coordinates in the correspondence analysis among the controls. The confounders were factors with crude significant association with ESCC (see Supplementary Table 2) , as well as conventional confounders observed in the literature, such as age and sex. Except for family history, the remaining adjusted confounders were significantly associated with alcohol consumption. ORs and 95% confidence intervals (CIs) were calculated by using the ancestral allele as references. The normalized coefficient of LD, D'-based LD patterns were calculated and presented visually by using the software LDmatrix (https:// analysistools.nci.nih.gov/LDlink/?tab¼ldmatrix).
We further conducted stratified analysis by sex and alcohol consumption. The gene-alcohol interaction was modeled by including their product term in a multivariable logistic regression model. The interaction was reported following the proposed procedures by Knol and VanderWeele. 21 The ratio of ORs was obtained from the product term in the logistic regression model as a measure of interaction on a multiplicative scale. The synergy index was calculated to measure the interaction on an additive scale by using the epi.interaction function in the R software package epiR (https://cran.r-project.org/ package¼epiR).
We used a two-step regression in the R software package mediation to conduct a mediation analysis. We first fit the mediator model in which the cumulative alcohol consumption was modeled as a function of rs671, the activated function of which may increase alcohol intake and other covariates (age, sex, smoking, oral hygiene, tea drinking, wealth score, and family history). Next, we modeled the outcome variable ESCC. The explanatory variables of the outcome model included the mediator, rs671, and the same set of covariates as used in the mediator model. We used the linear regression fit with least squares and the logistic regression for the mediator and outcome models, respectively.
All analyses were performed with R software (version 3.2.3, http://cran.r-project.org).
Information on alcohol consumption, sex, and family history is essential in risk analyses of alcohol-related variants for several reasons. 9 First, alcohol consumption could be a strong confounding variable and effect modifier in comparing genotypes and the risk of ESCC because genotypes are also related to alcohol consumption. They are possibly suppressive in the genotype ALDH2 AG/AA but facilitating in the genotype ADH1B AG/GG; thus, it can be misleading to interpret the effect on risk of ESCC without taking alcohol consumption into consideration. Second, from a mechanistic viewpoint of alcohol metabolism (see Supplementary Fig. 1 ), alcohol-related enzymes would not be expected to play a major role in the development of ESCC among alcohol nondrinkers, or among females who drink much less alcohol than males. Similarly, the adverse role of loss-of-function ADH and aldehyde dehydrogenase variants would be enhanced among alcohol drinkers. Third, the mechanism of tumorigenesis can be different between ESCC with and without a family history of the esophageal cancer. Thus, the analyses were performed by stratification according to alcohol consumption status, sex, and family history.
Development of Metabolizing Score
The alcohol-metabolizing process is complicated and regulated by more than a single locus or a single gene. Other than in the case of rs1229984, the function of ADH SNPs has been underreported. To study the cumulative effect of ADH SNPs in ESCC, a score based on observed association with ESCC risk was developed to empirically quantify the abundance level of ethanol-metabolizing enzyme. This was done with the assumption that a fast ethanol-metabolizing rate would result in accumulation of ethanal, thus increasing the risk of ESCC. For each individual, an empirical ethanol-metabolizing enzyme abundance level (E-MEAL) score was constructed by counting the number of risk genotypes, which were selected on the basis of their significant association with an increased risk of ESCC.
Role of the Funding Source
The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
We recruited 1418 case patients with ESCC and 1992 controls, among whom 111 case patients and nine controls did not have blood samples. To minimize recall bias, particularly with respect to alcohol consumption, 58 case patients were excluded from the analysis for awareness of their diagnoses before interview. Therefore, a candidate genetic association study was carried out by using a total of 1249 case patients and 1983 control subjects.
SNPs Associated with Susceptibility to ESCC
Demographic characteristics of the case patients and controls are shown in Table 1 . For both case patients and controls, the mean age was between 66 and 67 years, and about one-third were women. Smoking, alcohol, and tea drinking were more prevalent among the case patients than among the controls, whereas wealth score and daily frequency of brushing teeth were lower in case patients. In addition, case patients with ESCC more frequently reported a positive family history of esophageal cancer than the controls did.
The analyses of genotypic distribution in case patients with ESCC (n ¼ 1190) and controls (n ¼ 1883) showed a significant difference. Univariate analysis revealed 15 significant SNPs (p < 0.05). These SNP loci are located in three genomic regions on chromosomes 4, 10, and 12. Ten of the 15 SNPs lie within a 269-kilobase region showing LD (Supplementary Fig. 3B ). As expected, the strongest association was found for two loci, rs1159918 on gene ADH1B and rs3782886 on the wellknown gene ALDH2 for heterozygous genotype of the mutant allele (p ¼ Table 2 ). Had we corrected for multiple testing by using the most stringent Bonferroni approach (p < 0.0016), five SNPs would have still been significant, including the major SNPs of interest, rs1042026 and rs671. Subgroup analysis stratified by sex, alcohol consumption, and family history was performed in the same way as presented in Table 2 to check whether the susceptible effects of alcohol metabolism-related polymorphisms on risk of ESCC were different among strata. Few significant associations were detected in subgroup analyses among females, non-alcohol drinkers, and those with a family history of esophageal cancer (Supplementary Tables 3-5) .
The results of stratified analysis showed that alcohol consumption greatly influenced the OR for rs1042026 (ADH1B) between drinkers and nondrinkers, indicating a gene-environment interaction (see Supplementary  Table 3 ). The rs1042026 GG genotype was associated with a moderate (aOR ¼ 0.46, 95% CI: 0.28-0.74) but significantly decreased risk of ESCC among drinkers. However, there was a null association among nondrinkers. For rs671 heterozygotes (ALDH2), the results of the stratified analysis showed that the ORs differed between alcohol drinkers and non-alcohol drinkers (aOR ¼ 1.98 versus 1.20), clearly demonstrating a very strong gene-environment interaction. Rs671 AA decreased the cancer risk among drinkers, although the proportion of drinkers among the rs671 homozygotes AA was very April 2019 Alcohol Intake, ALDH2, ADH, and ESCC Risk small. In subsequent analysis, we removed individuals with the rs671 genotype AA owing to the small sample size.
Association between ALDH2/ADH1B Genes and Alcohol Consumption and Their Interaction in ESCC Susceptibility
Using rs1042026 as a surrogate marker, we stratified by ethanol oxidization functionality and showed that ALDH2 had a great impact on alcohol consumption among individuals with an increased rate of ethanol oxidization (i.e., those carrying the rs1042026 genotypes GG and AG [ 2.93 (95% CI: 1.39-6.35), respectively. This indicated that the estimated joint effect on the OR scale of cumulative alcohol consumption and the ALDH2 AG genotype together was greater than the product of the estimated effects of cumulative alcohol consumption alone and the AG genotype alone, so that there was a positive interaction on the multiplicative scale too. Among individuals with a relatively slow ethanol oxidization rate, we followed the same procedures to investigate the interaction (Table 4) . No interaction was observed between rs671 and alcohol consumption for ESCC risk either on the multiplicative or on the additive scale. Cumulative alcohol consumption was a risk factor here with boundary significance, but ALDH2 was not. We observed no difference in alcohol consumption between genotype GG and genotype AG of rs671 in the controls (see Table 4 ). We noticed that the percentage of alcohol drinkers was 45.5% on average, which was lower than the rate of 52.5% observed in all the controls (n ¼ 1239) and higher than the rate of 23.7% that was observed in individuals with low acetaldehyde oxidization activity and normal rates of ethanol oxidization. Figure 1 displays ORs for the eight subgroups as defined by the three dichotomized factors of alcohol consumption, ADH1B SNPs, and ALDH2 SNPs in relation to ESCC risk, in order to better understand their complex relationship. Alcohol drinkers with an increased ethanol-metabolizing rate and inactive acetaldehyde oxidization function are likely to experience the most severe accumulation of harmful acetaldehyde. However, the observed aOR for the subgroup is 5.12 (95% CI: 1.98-13.24), which is lower than for alcohol drinkers with a slow ethanol-metabolizing function (aOR ¼ 6.54 [95% CI: 2.11-20.24] and aOR ¼ 6.30 [95% CI: 2.02-19.62], respectively) (see Fig. 1 ).
Subsequently, we refined the alcohol consumption level for never-drinkers, moderate drinkers (cumulative drinking amount <2250 g/day-years), and heavy drinkers (cumulative drinking amount !2250 g/dayyears). The association between ESCC and cumulative alcohol consumption was studied within the strata of ethanol and ethanal oxidization rate. Figure 2A showed that individuals with genotype rs671 GG (ethanal-fast) and rs1042026 GG/AG (ethanol-fast) had the lowest risk of ESCC, regardless of cumulative alcohol consumption level, whereas the other three subgroups had a remarkably higher risk of ESCC. The aOR can be as high as 6.32 (95% CI: 3.79-10.53) for heavy drinkers with genotype rs671 GG (ethanal-fast) and rs1042026 AA (ethanal-slow). The number of individuals with slow ethanol conversion was very small. Notably, the expected high-risk groups of those most likely to experience Proportion of drinkers in controls among different genotypes: of the controls with rs671 genotype GG, 19 were never-drinkers and 15 (44.1%) were drinkers, and of the controls with rs671 genotype AG, 17 were never-drinkers and 15 (46.9%) were drinkers.
ALDH2, aldehyde dehydrogenase 2 family member gene; CI, confidence interval; aOR: adjusted OR.
severe accumulation of harmful acetaldehyde, namely, those with fast ethanol oxidization and a slow ethanal oxidization rate, did not have the highest observed aORs. A joint analysis of multiple ADH SNP loci is warranted.
The function of the SNPs may influence alcohol intake. It may be useful to perform a mediation analysis of alcohol consumption and, in addition, to adjust it for the analysis of the main effect of the SNPs. The estimated average causal mediation effects, estimated average direct effects, and total effects are all significantly different from zero. The results suggest that activated ALDH2 might result in increased alcohol consumption, which in turn makes subjects more likely to experience development of ESCC.
Cumulative Effect of Alcohol MetabolismRelated Genes
We performed an analysis of the joint effects of alcohol consumption and the following SNPs: rs1229977 in ADH1A, rs1042026 and rs17033 in ADH1B, rs1614972 and rs1789903 in ADH1C, rs3805322 in ADH4, rs1312200 in the neighborhood of ADH5, rs10008281 and rs1893883 in the neighborhood of ADH6 or in ADH6, rs1442490 in the neighborhood of ADH7, and rs671 in ALDH2 in relation to the risk of developing ESCC. On average, one or two SNPs were selected per gene to construct the E-MEAL score.
In line with our expectation, E-MEAL score was not associated with ESCC risk in nondrinkers. In fact, all four subgroups had a consistent spectrum of ORs. Heavy alcohol drinkers with higher E-MEAL scores (ethanol-fast) and ALDH2 deficiency (ethanal-slow) had an approximately 10-fold higher risk of development of ESCC compared with individuals who had lower E-MEAL scores (ethanol-slow) and active ALDH2 (ethanal-fast) regardless of their cumulative levels of alcohol consumption. When E-MEAL score is low, the aOR of rs671 genotype AG was 2.63 (95% CI: 1.70-4.06) in moderate drinkers and 5.33 (95% CI: 3.02-9.39) in heavy drinkers (Fig. 2B) .
Discussion
Most recently, Garaycoechea et al. 22 presented evidence of DNA damage caused by acetaldehyde at the molecular level. In this candidate genetic case-control study, we examined the damaging role of different acetaldehyde exposure levels at the population level. Using 1190 case patients and 1883 controls, we identified 15 susceptibility loci associated with susceptibility to ESCC risk. Among these loci, two functional SNPs had a significant interaction with alcohol consumption, which is an important lifestyle risk factor in the development of ESCC. To our knowledge, this is one of the first large studies to explore gene-alcohol interactions and the risk of development of ESCC by incorporating alcoholmetabolizing-related gene function information into analysis in Chinese population.
We found that the most significant interaction region was for variants at 12q24 harboring ALDH2, which encodes aldehyde dehydrogenase 2 (which consequently detoxifies acetaldehyde to acetate). The directions of our associations reported here are consistent with those Figure 1 . Association between ethanol oxidization rate (x axis) and acetaldehyde-metabolizing rate (y axis) and risk of esophageal squamous cell carcinoma in alcohol drinkers and non-alcohol drinkers, respectively. Boldface numbers in the blue and white rectangle regions represent ORs in the subgroups that are defined by rs671 and rs1042026 genotypes, where fast ethanol oxidization rate refers to rs1042026 (AG/GG), slow ethanol oxidization rate refers to rs1042026 (AA), fast acetaldehyde oxidization rate refers to rs671 (GG), and slow acetaldehyde oxidization rate refers to rs671 (AG). Non-alcohol drinkers who have a slow ethanol oxidization rate and fast acetaldehyde oxidization rate have the lowest risk and thus are used as the reference group. A, alanine; G, guanine.
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Alcohol Intake, ALDH2, ADH, and ESCC Riskreported in previous studies. We primarily focused on two functionally well studied variants, rs671 and rs1229984, which have a profound effect in regulating alcohol metabolism. A commonly used method is to have an SNP serve as a surrogate marker for study of ethanol oxidation function. It has been reported that ADH1B SNP results in different catalytic activity. 23, 24 On the basis of the surrogate marker, the vast majority of Chinese individuals are classified as having increased rate of ethanol oxidation in our study. 7, 25, 26 Moreover, the rate of ethanol conversion could depend on more than one ADH variant. We developed a score to empirically quantify the abundance level of ethanol-metabolizing enzyme on the basis of the observed association between ADH genes and ESCC risk.
The SNP analysis shows that variants of the ALDH2 and ADH1B genes are associated with an increased risk of ESCC. In the stratified analysis, the disappearance of significant association of the SNPs with ESCC in certain subgroups suggests that the genetic effects of alcohol metabolism-related SNPs have an impact mainly on alcohol drinkers and males because of the of low rates of alcohol consumption by females. This is in line with our expectation.
Furthermore, we evaluated the joint effects of variants in ADH1B and ALDH2 and alcohol consumption on ESCC risk. The findings clearly indicate a gene-lifestyle interaction between alcohol consumption and genetic variation (rs671 genotype GG/AG) in the alcohol-metabolizing pathway among individuals with a fast ethanol oxidization rate. We have provided a power calculation for this subgroup analysis. 27 Given 987 case patients, a control-to-case ratio of 1:6, the observed sample size in each category, and the observed OR for interaction being 3.16, the statistical power would be as high as 95%. Had a more conservative OR of 2 been considered, the statistical power could have reached 80%.
Given that ADHs oxidize alcohol to the known carcinogen acetaldehyde, which is then detoxified by aldehyde dehydrogenases, it is thought that individuals with the combination of a fast alcohol-metabolizing genotype and a slow acetaldehyde-metabolizing genotype would be the most susceptible to ESCC. However, it tends to be that drinking behavior in these individuals is strikingly different from that of individuals with normal alcohol-metabolizing functions.
With similar alcohol consumption behavior and levels consumed in the population, alcohol drinkers with a fast Figure 2 . Association between esophageal squamous cell carcinoma and alcohol consumption under certain metabolic capacity of alcohol. (A) Analysis stratified by genotypes of rs671 and rs1042026. The subgroups are labeled and defined as follows: ethanol-fast, fast ethanol oxidization rate for rs1042026 genotype AG/GG; ethanol-slow, slow ethanol oxidization rate for rs1042026 genotype AA; ethanal-fast, fast ethanal-metabolizing rate for rs671 genotype GG; and ethanal-slow, slow ethanal-metabolizing rate for rs671 genotype AG. (B) Stratified analysis by genotypes of rs671 and ethanol-metabolizing enzyme abundance level (E-MEAL) score. The subgroups are labeled and defined as follows: ethanol-fast, fast ethanol oxidization rate for E-MEAL less than 1; ethanol-slow, slow ethanol oxidization rate for E-MEAL score of 1 or higher; ethanol-fast, fast ethanal-metabolizing rate for rs671 genotype GG; and ethanal-slow, slow ethanal-metabolizing rate for rs671 genotype AG. A, alanine; G, guanine.
ethanol-metabolizing rate and slow acetaldehyde oxidization function are thought to be the group most prone to ESCC development owing to accelerated acetaldehyde accumulation in the body. However, the observed ORs are not entirely in line with this theory, which could be due to several factors: (1) The proportion of drinkers among the controls with fast ethanol-and slow ethanalmetabolizing rates is substantially lower than among the other groups, meaning that the drinking behavior is altered, resulting in a lower OR; (2) the complex alcoholmetabolizing mechanism, especially for conversion from ethanol to acetaldehyde, is not regulated by a single SNP or a single gene, as a result of which the defined groups that metabolize acetaldehyde and ethanol quickly versus slowly may be crude; (3) the sample sizes in the subgroups of individuals with a relatively slow ethanol oxidization rate were small; and (4) the definition of alcohol drinkers is too broad. Further refinement is desired because the expected hazardous level assumes that all subgroups consume the same amount of alcohol. Therefore, we further investigated the SNP loci with more detailed information on the levels of alcohol consumption by never-drinkers, moderate drinkers, and heavy drinkers.
Stratification according to the status of alcohol consumption is essential to accurately assess the effects of ALDH2 and ADH1B genotypes on cancer risk. The ALDH2 rs671 A allele plays a suppressive role in alcohol consumption, whereas ADH1B rs1042026 A allele is reported to play a facilitating role. 9 However, we found an interesting role of ADH1B, which can be either inhibiting or tentatively facilitating depending on the functionality of the gene ALDH2. Specifically, among individuals with an inactive acetaldehyde oxidization function, the increased ethanol metabolism rate accelerates the accumulation of acetaldehyde, which leads to inhibition of alcohol consumption (46.9% / 23.7%). Interestingly, when acetaldehyde oxidization is activated, the direction of ADH1B in influencing alcohol consumption behavior is reversed, although this is not statistically significant (44.1% / 54.3%). Depending on whether ALDH2 was activated, we observed either a facilitating or a tentatively suppressive role in alcohol consumption.
In the stratified analysis by ethanol oxidization rate, those who never drank were used as the reference group. Case patients with ESCC who were never-drinkers may have a disease mechanism different from that of everdrinkers and are likely to be more ill. We used family history and body mass index as surrogates for the level of sickness. The results showed no difference in family history between patients who were never-drinkers versus ever-drinkers but had a difference in body mass index (p value ¼ 0.01). Case patients with ESCC who never drank were more likely to be underweight or overweight.
Further studies on the underlying mechanism of ESCC in never-drinkers would be of great interest. Nevertheless, an increasing trend in ESCC risk was observed when never-drinker was used as the reference, indicating that drinkers with a certain genotype have a higher risk of ESCC, regardless of the underlying mechanisms.
The selected 31 SNPs to genotype in our study may not be thorough. Nevertheless, we have tried to make sure that the best-known SNPs, rs671, rs1229984, and rs1042026, are included in our initial genotyping list.
Potential recall bias is unavoidable in case-control studies. To minimize it, we tried to enroll the case patients before they were aware of their diagnosis. As shown in Supplementary Figure 2 , only case patients who were surveyed before diagnosis were included in the analysis, thus allaying the concern of recall bias.
The percentage of subjects who did not have blood samples was higher in the case patients than in the controls, which is partially due to the fact that patients are physically too ill to donate blood samples. Furthermore, case patients are generally more likely to refuse because the blood collection procedure is performed immediately after an invasive biopsy procedure, which possibly causes further patient discomfort and pain.
We highlight a continual research gap in understanding the relationship of ESCC with alcohol consumption and alcohol metabolism-related genes, by comparing (1) the observed risk groups defined by two risk loci, rs671 and rs1042026 with known alcoholmetabolizing function and (2) those defined by a composite score, E-MEAL, to empirically measure aggregated level of abundance of ethanol-metabolizing enzyme on the basis of the association with ESCC for multiple SNPs. Further functional studies of a comprehensive list of genetic variants causing disturbance of alcohol metabolism would be the foundation for revealing the pathogenesis of ESCC. Alternatively, a statistical approach may be useful for compensating for the current research gap, providing insight into understanding ESCC carcinogenesis, and contributing to prevention of the disease.
There are an increasing number of findings that reiterate the causative role of alcohol in cancer. Our results suggest that both genetic variants in ADH1B and ALDH2 increase alcohol drinkers' susceptibility to ESCC. This observation highlights the need to scale up efforts in preventing excessive use of alcohol at all levels, especially in individuals with both active ADH variants and inactive ALDH2 variants.
